This is not a concern at standard dosages (1040 mcg/day) for under 8 weeks, but should be avoided by those with a history of cancer or uncontrolled growth conditions
J Plast Reconstr aesthetic Surg 63(7):11861195 Hershman DL, Unger JM, Crew KD, Minasian LM, Awad D, Moinpour CM et al (2013) Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy
Doctors typically prescribe Zepbound for weight management alongside a calorie-restricted diet and an exercise plan
Symptoms may include fatigue, loss of appetite, or high blood pressure
The FDA warns that both CJC-1295 and ipamorelin are risky for immunogenicity, potentially causing life-threatening outcomes such as anaphylaxis.25 26 Cardiovascular concerns: Specifically concerning CJC-1295, the FDA warns of the risk of increased heart rate and systemic vasodilatory reaction, including flushing, warmth, and transient hypotension.25 27 Cancer: With their ability to increase the rate of cellular replication, growth hormone secretagogues in general are unsafe for cancer survivors and people with an active cancer diagnosis.28 Secretagogue use may elevate their risk for recurrence or worsen their prognosis
SURMOUNT-5 proved superiority over semaglutide 2.4 mg (20.2% vs 13.7%)